ESR1 and breast cancer: This correlation was also evident in triple-negative breast cancer (TNBC), the most aggressive subtype of breast cancer characterized by the absence of Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2 (Fig. 6c).